4Chu CJ,Hussain M,Lok AS.Hepatitis B virus genotype B is as sociate with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.Gastroenterol,2002,122:1756-1762.
5Kao JH,Chen PJ,Lai MY,et al.Hepatitis B virus genotype and spontaneous hepatitis B e antigen seroconversion in Taiwan Residents hepatitis B carriers.J Med Virol,2004,72:363-369.
6McMahon BJ.The natural history of chronic hepatitis B virus infection.Semin Liver Dis,2004,24:17-21.
二级参考文献9
1Chen CJ,Yang HI,Su J,et al.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.JAMA,2006,295:65-73.
2Lok AS,McMahon B.Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
3Keeffe EB,Dieterich DT,Han SH,et al.A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.Clin Gastroenterol Hepatol,2004,2:87-106.
4Keeffe EB,Dieterich DT,Hah SH,et al.A treatment algorithm for the management of chronic hepatitis B virus infection in the United States:an update.Clin Gastroenterol Hepatol,2006,4:936-962.
5Dieterich DT.Emerging data and clinical consensus should dictate care.AGA perspectives,2006,2:5,13.
6Soderstrom A,Lindh M,Ekholm K,et al.Predictive factors and virological response to interferon treatment in children with chronic hepatitis B.Scand J Infect Dis,2005,37:40-47.
7Lai CL,Gane E,Liaw YF,et al.Maximal early HBV suppression is predictive of optimal virologic and clinical efficacy in nucleoside-treated hepatitis B patients:scientific observations from a large multinational trial (the GLOBE study)[abstract].Hepatology,2005,42:232A-233A.
8ter Borg MJ,van Zonneveld M,Zeuzem S,et al.Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B:relation to treatment response.Hepatology,2006,44:721-727.
9Yim HJ,Lok ASF.Natural History of Chronic hepatitis B virus infection:what we knew in 1981 and what we know in 2005.Hepatology,2006,43:S173-S181.
